During the past decade, CHU de Limoges - Hopital Mere Enfant conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU de Limoges - Hopital Mere Enfant" #1 sponsor was "Allergan" with 2 trials, followed by "Centre Hospitalier Universitaire de Saint Etienne" with 1 trials sponsored, "Institut Curie" with 1 trials sponsored, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials sponsored and "NCIC Clinical Trials Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU de Limoges - Hopital Mere Enfant" #1 collaborator was "Grupo Espanol de Investigacion del Cancer de Mama" with 1 trials as a collaborator, "Ligue contre le cancer, France" with 1 trials as a collaborator, "National Research Agency, France" with 1 trials as a collaborator, "Programme hospitalier de recherche clinique, France" with 1 trials as a collaborator and "UNICANCER" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "CHU de Limoges - Hopital Mere Enfant" are "Urinary Incontinence" (2 trials), "Breast Cancer" (1 trials), "CIN2/3 Recurrence" (1 trials), "Central Nervous System Tumor" (1 trials) and "Childhood Solid Tumor" (1 trials). Many other conditions were trialed in "CHU de Limoges - Hopital Mere Enfant" in a lesser frequency.

Most popular intervention types in "CHU de Limoges - Hopital Mere Enfant" are "Other" (3 trials), "Biological" (2 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "OnabotulinumtoxinA" (2 trials), "Sampling on blood, bone marrow and cerebrospinal fluid" (1 trials), "Study Follow-Up" (1 trials), "blood sample" (1 trials) and "exemestane" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU de Limoges - Hopital Mere Enfant" are 5 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "CHU de Limoges - Hopital Mere Enfant". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in CHU de Limoges - Hopital Mere Enfant, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CHU de Limoges - Hopital Mere Enfant, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".